PRESENTATION: 10 ml and 50 ml clear glass vial
If approved, CagriSema would provide patients and healthcare professionals with an additional treatment option supported by results from the REDEFINE clinical program, including robust efficacy, high treatment completion rates, and a tolerability profile consistent with its underlying pharmacology
The three peptides are physically and chemically compatible in solution for the short period between drawing and injecting
Gupta, K., Singh, S., and van Hoek, M.L., Antibiotics (Basel) , 2015, vol
As with any compounded medication, administration should be performed by qualified personnel familiar with sterile injection techniques and patient monitoring